AMGN - Amgen Inc. 0 WATCHERS

If it sparks some ideas, heres my portfolio Holdings 45 35% BRK.B 30% TFX (Custom tech foundations pie) +521% > 5Y 20% AVGO 12% NVDA 10% EQIX 9% GOOGL 9% AMZN 8% PLTR 6% ANET 6% CRWD 6% PANW 5% IBM 15% CEF (Costom Clean energy foundations pie) 350% > …

my portfolio Holdings 45 35% BRK.B 30% TFX (Custom tech foundations ETF) +521% > 5Y 20% AVGO 12% NVDA 10% EQIX 9% GOOGL 9% AMZN 8% PLTR 6% ANET 6% CRWD 6% PANW 5% IBM 15% CEF (Costom Clean energy foundations ETF) 350% > 5Y 21% PWR 18% NEE 13% …

PREMARKET NEWS REPORT 26/11 * Bernstein on new IRA pricing: Many (five) of the drugs included in the 15 face a patent cliff in or before 2027 & are unlikely to experience even a full year of price reduction before erosion kicks-in, so the IRA impact is limited. * Beyond …

Premarket News Report 26/11 * Bernstein on new IRA pricing: Many (five) of the drugs included in the 15 face a patent cliff in or before 2027 & are unlikely to experience even a full year of price reduction before erosion kicks-in, so the IRA impact is limited. * Beyond …

I have been transitioning from tech into a portfolio more geared towards income currently @ about 95k in qualified dividends hoping to triple that in 8 years as i put a foot one out the door. ADP AUTOMATIC DATA PROCESSING INC COM AFL AFLAC INC COM AMGN AMGEN INC AOS …

I spent some time on small cap biotech in early 2025 and concluded financial disclosures alone aren't enough to buy. Most have no earnings and are just looking for the next hot drug. It seems like you need to know their patent application pipeline - which is a lot of …

WMT, RSG, and WM are all great, stable businesses. But all 3 of them are horrendously overvalued right now which could seriously limit any potential upside if you're buying at their current share prices. PGR might have some modest undervaluation. I'd say MO is finally trading around fair price, not …